Back to search

National and Kapodistrian University of Athens

Διερεύνηση της απορρύθμισης των γονιδίων HER2/neu και PTEN στο μη μικροκυτταρικό καρκίνο του πνεύμονα

Abstract

dc:description

Backround: HER2/neu overexpression due to gene amplification is an important factor in breast cancer modifying the sensitivity to anti-HER-2/neu monoclonal antibody therapy. The clinical significance of HER2/neu expression in non-small-cell lung carcinoma (NSCLC) is currently under evaluation. The tumor suppressor gene PTEN negatively regulates the HER2/PI3K/Akt signalling pathway and plays an important role in cell cycle regulation and apoptosis. Although the loss of PTEN is not a rare event in NSCLC its prognostic role is still not well established. Purpose: The purpose of this study was to evaluate the role of HER2/neu oncogene in both gene and protein level and the role of PTEN tumor suppressor gene in protein level in NSCLC. Emphasis was given to investigate the role of simultaneous HER2 and PTEN protein expression alterations in relation to prognosis of NSCLC patients. Materials and methods: Surgical specimens were obtained from a total of 61 patients with NSCLC who underwent a surgical resection. Immunohistochemistry was performed by the use of anti-HER2/neu monoclonal antibody (TAB 250) and anti-PTEN polyclonal antibody (PN 37). Chromogenic in situ hybribization was applied based on the use of HER2/neu gene and chromosome 17 centromeric probes. Protein expression levels were evaluated using an image analysis system and finally statistical analysis was performed. Patients followed-up in a period of 34 to 41 months after the operation. Results: HER2 overexpression (2+/3+ score) was detected in 17 (27.87%) patients. Additionally, loss of PTEN expression was observed in 24 (39.34%) cases, low expression in 29 (47.54%) and overexpression in 8 (13.12%) cases. Gene analysis identified 4/61(6.56%) HER2/neu low-level gene amplified cases. Chromosome 17 analysis detected aneuploidy in 2/61(3.28%) cases. Simultaneous HER2 overexpression and PTEN low/loss of expression were correlated to the occurrence of metastases. (71,43% vs 36,17% p=0.03). Strong relationship between the number of positive regional lymph node stations during the time of operation and simultaneous deregulation of the two genes was revealed (p=0.04). Multivariate analysis determined that HER2 overexpression was associated with an increasing risk of developing metastases (OR: 4.3; 95%CI: 1.2-15.9; p: 0.03) while PTEN overexpression was associated with lower risk to develop metastases (OR: 0.1; 95%CI: 0.1, 1.0; p: 0.05). According to the findings of survival analysis, poor survival was significantly associated with the occurrence of metastasis (p=0.002), increasing tumor size (p=0.02), pTNM stage (p=0.01) and lymph node status (p=0.01). Conclusions: Simultaneous HER2 and PTEN deregulation is a significant genetic event that is likely to offer in the progression of NSCLC.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Panagiotou, Ioannis
  • Παναγιώτου, Ιωάννης

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29707

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Panagiotou, Ioannis; Παναγιώτου, Ιωάννης. Διερεύνηση της απορρύθμισης των γονιδίων HER2/neu και PTEN στο μη μικροκυτταρικό καρκίνο του πνεύμονα. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/29707